At the news
? NEUTRALIMPACT 4/10 144 filed Jun 9, 2026 at 18:01 ET
CEO Herriot Tabuteau files Form 144 to sell 49,670 shares of Axsome Therapeutics (~$12.2M) under a 10b5-1 plan dated 3/10/2026. The sale is pre-planned but adds to recent insider selling activity.
- CEO Herriot Tabuteau files to sell 49,670 shares (~$12.2M) under a 10b5-1 plan.
- The 10b5-1 plan was established on 3/10/2026, indicating pre-planned sale.
- Recent insider selling (30d) totals $19.9M, with this filing adding to the trend.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access